Linkage analysis of 49 high-risk families does not support a common familial prostate cancer susceptibility gene at 1q24-25

被引:97
作者
McIndoe, RA
Stanford, JL
Gibbs, M
Jarvik, GP
Brandzel, S
Neal, CL
Li, S
Gammack, JT
Gay, AA
Goode, EL
Hood, L
Ostrander, EA
机构
[1] FRED HUTCHINSON CANC RES CTR,DIV CLIN RES M 318,SEATTLE,WA 98104
[2] FRED HUTCHINSON CANC RES CTR,DIV PUBL HLTH,SEATTLE,WA 98104
[3] UNIV WASHINGTON,DEPT MOL BIOTECHNOL,SEATTLE,WA 98195
[4] UNIV WASHINGTON,MED CTR,DEPT MED,DIV MED GENET,SEATTLE,WA 98195
[5] UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,DEPT EPIDEMIOL,SEATTLE,WA 98195
关键词
D O I
10.1086/514853
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Linkage of a putative prostate cancer-susceptibility locus (HPC1) to chromosome 1q24-25 has recently been reported. Confirmation of this linkage in independent data sets is essential because of the complex nature of this disease. Here we report the results of a linkage analysis using 10 polymorphic markers spanning similar to 37 cM in the region of the putative HPC1 locus in 49 high-risk prostate cancer families. Data were analyzed by use of two parametric models and a nonparametric method. For the parametric LOD-score method, the first model was identical to the original report by Smith and coworkers (''Hopkins''), and the second was based on a segregation analysis previously reported by Carter and coworkers (''Seattle''). In both cases, our results do not confirm the linkage reported for this region. Calculated LOD scores from the two-point analysis for each marker were highly negative at small recombination fractions. Multipoint LOD scores for this linkage group were also highly negative. Additionally, we were unable to demonstrate heterogeneity within the data set, using HOMOG. Although these data do not formally exclude linkage of a prostate cancer-susceptibility locus at HPC1, it is likely that other prostate cancer-susceptibility loci play a more critical role in the families that we studied.
引用
收藏
页码:347 / 353
页数:7
相关论文
共 31 条
[1]  
BOOKSTEIN R, 1993, CANCER RES, V53, P3369
[2]  
BOOKSTEIN R, 1994, J CELL BIOCH S, V19, P217
[3]   Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer [J].
Bova, GS ;
MacGrogan, D ;
Levy, A ;
Pin, SS ;
Bookstein, R ;
Isaacs, WB .
GENOMICS, 1996, 35 (01) :46-54
[4]  
BOVA GS, 1993, CANCER RES, V53, P3869
[5]  
Brooks JD, 1996, CANCER RES, V56, P3814
[6]   ALLELIC LOSS OF CHROMOSOME-16Q AND CHROMOSOME-10Q IN HUMAN PROSTATE-CANCER [J].
CARTER, BS ;
EWING, CM ;
WARD, WS ;
TREIGER, BF ;
AALDERS, TW ;
SCHALKEN, JA ;
EPSTEIN, JI ;
ISAACS, WB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :8751-8755
[7]   MENDELIAN INHERITANCE OF FAMILIAL PROSTATE-CANCER [J].
CARTER, BS ;
BEATY, TH ;
STEINBERG, GD ;
CHILDS, B ;
WALSH, PC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) :3367-3371
[8]   HEREDITARY PROSTATE-CANCER - EPIDEMIOLOGIC AND CLINICAL-FEATURES [J].
CARTER, BS ;
BOVA, GS ;
BEATY, TH ;
STEINBERG, GD ;
CHILDS, B ;
ISAACS, WB ;
WALSH, PC .
JOURNAL OF UROLOGY, 1993, 150 (03) :797-802
[9]  
CAVALLISFORZA LL, 1986, AM J HUM GENET, V38, P599
[10]  
COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252